Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South
- PMID: 23651105
- PMCID: PMC3651686
- DOI: 10.1089/apc.2012.0322
Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South
Abstract
Promoting HIV medication adherence is basic to HIV/AIDS clinical care and reducing transmission risk and requires sound assessment of adherence and risk behaviors such as substance use that may interfere with adherence. The present study evaluated the utility of a telephone-based Interactive Voice Response self-monitoring (IVR SM) system to assess prospectively daily HIV medication adherence and its correlates among rural substance users living with HIV/AIDS. Community-dwelling patients (27 men, 17 women) recruited from a non-profit HIV medical clinic in rural Alabama reported daily medication adherence, substance use, and sexual practices for up to 10 weeks. Daily IVR reports of adherence were compared with short-term IVR-based recall reports over 4- and 7-day intervals. Daily IVR reports were positively correlated with both recall measures over matched intervals. However, 7-day recall yielded higher adherence claims compared to the more contemporaneous daily IVR and 4-day recall measures suggestive of a social desirability bias over the longer reporting period. Nearly one-third of participants (32%) reported adherence rates below the optimal rate of 95% (range=0-100%). Higher IVR-reported daily medication adherence was associated with lower baseline substance use, shorter duration of HIV/AIDS medical care, and higher IVR utilization. IVR SM appears to be a useful telehealth tool for monitoring medication adherence and identifying patients with suboptimal adherence between clinic visits and can help address geographic barriers to care among disadvantaged, rural adults living with HIV/AIDS.
Figures

Similar articles
-
Agreement between prospective interactive voice response telephone reporting and structured recall reports of risk behaviors in rural substance users living with HIV/AIDS.Psychol Addict Behav. 2011 Mar;25(1):185-90. doi: 10.1037/a0022725. Psychol Addict Behav. 2011. PMID: 21443312 Free PMC article.
-
Interactive voice response self-monitoring to assess risk behaviors in rural substance users living with HIV/AIDS.AIDS Behav. 2012 Feb;16(2):432-40. doi: 10.1007/s10461-011-9889-y. AIDS Behav. 2012. PMID: 21311964 Free PMC article.
-
Feasibility and reliability of interactive voice response assessment of HIV medication adherence: research and clinical implications.HIV Clin Trials. 2012 Sep-Oct;13(5):271-7. doi: 10.1310/hct1305-271. HIV Clin Trials. 2012. PMID: 23134627 Free PMC article.
-
Interactive voice response technology to measure HIV-related behavior.Curr HIV/AIDS Rep. 2009 Nov;6(4):210-6. doi: 10.1007/s11904-009-0028-6. Curr HIV/AIDS Rep. 2009. PMID: 19849964 Review.
-
Substance use: impact on adherence and HIV medical treatment.Curr HIV/AIDS Rep. 2011 Dec;8(4):223-34. doi: 10.1007/s11904-011-0093-5. Curr HIV/AIDS Rep. 2011. PMID: 21858414 Review.
Cited by
-
Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care.AIDS Behav. 2017 Jul;21(7):1996-2004. doi: 10.1007/s10461-017-1716-7. AIDS Behav. 2017. PMID: 28213820 Free PMC article.
-
Utilization, receptivity and reactivity to Interactive Voice Response daily monitoring in risky drinking smokers who are motivated to quit.Tob Induc Dis. 2018 May 30;16:25. doi: 10.18332/tid/84972. eCollection 2018. Tob Induc Dis. 2018. PMID: 31516425 Free PMC article.
-
'The phone reminder is important, but will others get to know about my illness?' Patient perceptions of an mHealth antiretroviral treatment support intervention in the HIVIND trial in South India.BMJ Open. 2015 Nov 2;5(11):e007574. doi: 10.1136/bmjopen-2015-007574. BMJ Open. 2015. PMID: 26525717 Free PMC article.
-
Mobile health treatment support intervention for HIV and tuberculosis in Mozambique: Perspectives of patients and healthcare workers.PLoS One. 2017 Apr 18;12(4):e0176051. doi: 10.1371/journal.pone.0176051. eCollection 2017. PLoS One. 2017. PMID: 28419149 Free PMC article. Clinical Trial.
-
Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development.J Clin Psychopharmacol. 2015 Oct;35(5):566-73. doi: 10.1097/JCP.0000000000000372. J Clin Psychopharmacol. 2015. PMID: 26244381 Free PMC article. Review.
References
-
- National Institutes of HealthWeb site. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. [Sep 7;2012 ]. www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
-
- Gao X. Nau DP. Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother. 2000;34:1117–1112. - PubMed
-
- Lu M. Safren SA. Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12:86–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical